EDITORIAL · ABOUT
About MD CJC-1295
An independent editorial project that reads the CJC-1295 research record straight — and is explicit about what it is not.
What This Site Is
MD CJC-1295 is an independent editorial project that publishes summaries of the peer-reviewed research literature on CJC-1295. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The site exists because the popular literature on CJC-1295 is unusually muddled — the long-acting DAC form and the short-acting no-DAC Modified GRF (1-29) are conflated constantly, fixed-microgram 'protocols' are presented as if trial-derived, and the thin human evidence base is often overstated. The remedy we offer is narrow and specific: read the published studies, keep the forms apart, tag each finding by species and evidence tier, and mark the gaps.
On the 'MD' in the Name
The 'MD' in MD CJC-1295 is editorial framing, not a claim about services. It signals the register this site reads in — a measured, source-anchored reading of a clinical literature — not the presence of a physician, a clinic, or a practice. There are no doctors here, no pharmacists, no clinical team, and no consultation, treatment, or prescription on offer.
We say this plainly because the distinction matters. A domain modifier is a position a publisher occupies relative to the research; it is not a service. Everything on this site is a reading of public science, and nothing on it is dispensed, prescribed, or sold.
How We Work
Every quantitative claim on this site maps to a numbered citation, and every citation resolves to a published study with a DOI or PubMed link. When the record is precise — the 5.8- to 8.1-day DAC half-life [1], the +7.5-fold basal GH response [3], the 4-fold GH AUC in the bioconjugate study [2] — we state the number and attribute it. When it is silent — no validated human dose, no long-term safety trial, no regulatory approval — we say so rather than fill the gap.
The layered design of this site is deliberate: the long-acting DAC evidence and the short-acting no-DAC evidence sit on separate panes, each finding wears a label naming its form and evidence tier, and the honest caveats are surfaced rather than buried. It is a reading room for the CJC-1295 record, organized so a reader can see at a glance which form and which tier any given point belongs to.